338 related articles for article (PubMed ID: 14500688)
61. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
62. Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine.
Wasik MA; Nowak I; Zhang Q; Shaw LM
Leuk Lymphoma; 1998 Feb; 28(5-6):551-60. PubMed ID: 9613985
[TBL] [Abstract][Full Text] [Related]
63. alpha-thrombin inhibits interleukin-6-induced Stat3 signaling and gp130 gene expression in primary cultures of human lung fibroblasts.
Bhat GJ; Raghu G; Gunaje JJ; Idell S
Biochem Biophys Res Commun; 1999 Mar; 256(3):626-30. PubMed ID: 10080949
[TBL] [Abstract][Full Text] [Related]
64. Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells.
Ye F; Chen HZ; Xie X; Ye DF; Lu WG; Ding ZM
Gynecol Oncol; 2004 Jul; 94(1):125-33. PubMed ID: 15262130
[TBL] [Abstract][Full Text] [Related]
65. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.
Shishodia S; Amin HM; Lai R; Aggarwal BB
Biochem Pharmacol; 2005 Sep; 70(5):700-13. PubMed ID: 16023083
[TBL] [Abstract][Full Text] [Related]
66. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways.
Xu Q; Briggs J; Park S; Niu G; Kortylewski M; Zhang S; Gritsko T; Turkson J; Kay H; Semenza GL; Cheng JQ; Jove R; Yu H
Oncogene; 2005 Aug; 24(36):5552-60. PubMed ID: 16007214
[TBL] [Abstract][Full Text] [Related]
67. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
68. Selective inhibition of STAT3 phosphorylation by sodium salicylate in cardiac fibroblasts.
Wang Z; Jiang B; Brecher P
Biochem Pharmacol; 2002 Apr; 63(7):1197-207. PubMed ID: 11960596
[TBL] [Abstract][Full Text] [Related]
69. IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells.
Liu Y; Fuchs J; Li C; Lin J
Cell Cycle; 2010 Sep; 9(17):3423-7. PubMed ID: 20818158
[TBL] [Abstract][Full Text] [Related]
70. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes.
Tanabe Y; Nishibori T; Su L; Arduini RM; Baker DP; David M
J Immunol; 2005 Jan; 174(2):609-13. PubMed ID: 15634877
[TBL] [Abstract][Full Text] [Related]
71. Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule.
Puthier D; Thabard W; Rapp M; Etrillard M; Harousseau J; Bataille R; Amiot M
Br J Haematol; 2001 Feb; 112(2):358-63. PubMed ID: 11167829
[TBL] [Abstract][Full Text] [Related]
72. A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells.
Lin L; Deangelis S; Foust E; Fuchs J; Li C; Li PK; Schwartz EB; Lesinski GB; Benson D; Lü J; Hoyt D; Lin J
Mol Cancer; 2010 Aug; 9():217. PubMed ID: 20712901
[TBL] [Abstract][Full Text] [Related]
73. Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes.
Erickson S; Matikainen S; Thyrell L; Sangfelt O; Julkunen I; Einhorn S; Grandér D
Eur J Biochem; 2002 Jan; 269(1):29-37. PubMed ID: 11784295
[TBL] [Abstract][Full Text] [Related]
74. Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3.
Wang LH; Yang XY; Mihalic K; Xiao W; Li D; Farrar WL
J Biol Chem; 2001 Aug; 276(34):31839-44. PubMed ID: 11429412
[TBL] [Abstract][Full Text] [Related]
75. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation.
Turkson J; Ryan D; Kim JS; Zhang Y; Chen Z; Haura E; Laudano A; Sebti S; Hamilton AD; Jove R
J Biol Chem; 2001 Nov; 276(48):45443-55. PubMed ID: 11579100
[TBL] [Abstract][Full Text] [Related]
76. Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway.
Yang CL; Liu YY; Ma YG; Xue YX; Liu DG; Ren Y; Liu XB; Li Y; Li Z
PLoS One; 2012; 7(5):e37960. PubMed ID: 22662257
[TBL] [Abstract][Full Text] [Related]
77. LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells.
Liu A; Liu Y; Li PK; Li C; Lin J
Anticancer Res; 2011 Jun; 31(6):2029-35. PubMed ID: 21737619
[TBL] [Abstract][Full Text] [Related]
78. Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells.
Amit-Vazina M; Shishodia S; Harris D; Van Q; Wang M; Weber D; Alexanian R; Talpaz M; Aggarwal BB; Estrov Z
Br J Cancer; 2005 Jul; 93(1):70-80. PubMed ID: 15970928
[TBL] [Abstract][Full Text] [Related]
79. A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cells.
Hideshima T; Mitsiades C; Ikeda H; Chauhan D; Raje N; Gorgun G; Hideshima H; Munshi NC; Richardson PG; Carrasco DR; Anderson KC
Blood; 2010 May; 115(18):3772-5. PubMed ID: 20228272
[TBL] [Abstract][Full Text] [Related]
80. Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway.
Ferlin M; Noraz N; Hertogh C; Brochier J; Taylor N; Klein B
Br J Haematol; 2000 Nov; 111(2):626-34. PubMed ID: 11122111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
